ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
142.2 EUR
0 (0%)
ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 70 industry peers in the Chemicals industry. ACT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACT has a decent growth rate and is not valued too expensively. With these ratings, ACT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year ACT was profitable.
In the past year ACT had a positive cash flow from operations.
ACT had positive earnings in each of the past 5 years.
Of the past 5 years ACT 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.49%, ACT belongs to the top of the industry, outperforming 95.71% of the companies in the same industry.
The Return On Equity of ACT (26.47%) is better than 95.71% of its industry peers.
ACT has a better Return On Invested Capital (13.45%) than 92.86% of its industry peers.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.86%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(13.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
The Profit Margin of ACT (10.97%) is better than 84.29% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
ACT has a Operating Margin of 15.93%. This is amongst the best in the industry. ACT outperforms 85.71% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
ACT has a Gross Margin of 66.55%. This is amongst the best in the industry. ACT outperforms 97.14% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
Compared to 1 year ago, ACT has less shares outstanding
Compared to 5 years ago, ACT has less shares outstanding
ACT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.82 indicates that ACT is not in any danger for bankruptcy at the moment.
ACT has a Altman-Z score of 4.82. This is amongst the best in the industry. ACT outperforms 87.14% of its industry peers.
ACT has a debt to FCF ratio of 1.32. This is a very positive value and a sign of high solvency as it would only need 1.32 years to pay back of all of its debts.
ACT has a Debt to FCF ratio of 1.32. This is amongst the best in the industry. ACT outperforms 94.29% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that ACT is not too dependend on debt financing.
ACT's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. ACT outperforms 72.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 4.82 |
ROIC/WACC1.9
WACC7.09%
2.3 Liquidity
A Current Ratio of 2.87 indicates that ACT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.87, ACT belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.77, ACT belongs to the best of the industry, outperforming 81.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 24.12% over the past year.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.05% in the last year.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
The Earnings Per Share is expected to grow by 20.26% on average over the next years. This is a very strong growth
ACT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.6%
Revenue Next 5Y6.02%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.31, the valuation of ACT can be described as rather expensive.
ACT's Price/Earnings is on the same level as the industry average.
ACT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.43.
With a Price/Forward Earnings ratio of 20.38, ACT is valued on the expensive side.
ACT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.66, ACT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.31 | ||
| Fwd PE | 20.38 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
The rest of the industry has a similar Price/Free Cash Flow ratio as ACT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.37 | ||
| EV/EBITDA | 12.18 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 19.49% in the coming years.
PEG (NY)1.28
PEG (5Y)0.95
EPS Next 2Y17.04%
EPS Next 3Y19.49%
5. Dividend
5.1 Amount
ACT has a Yearly Dividend Yield of 1.27%.
Compared to an average industry Dividend Yield of 2.49, ACT is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 1.87, ACT is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
49.16% of the earnings are spent on dividend by ACT. This is a bit on the high side, but may be sustainable.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
FRA:ACT (12/17/2025, 2:43:58 PM)
142.2
0 (0%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners37.98%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.45B
Revenue(TTM)563.86M
Net Income(TTM)61.84M
Analysts81.82
Price Target158.56 (11.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP49.16%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.83%
PT rev (3m)-1.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.31 | ||
| Fwd PE | 20.38 | ||
| P/S | 2.57 | ||
| P/FCF | 41.37 | ||
| P/OCF | 9.95 | ||
| P/B | 6.2 | ||
| P/tB | 6.29 | ||
| EV/EBITDA | 12.18 |
EPS(TTM)6.1
EY4.29%
EPS(NY)6.98
Fwd EY4.91%
FCF(TTM)3.44
FCFY2.42%
OCF(TTM)14.3
OCFY10.06%
SpS55.39
BVpS22.95
TBVpS22.6
PEG (NY)1.28
PEG (5Y)0.95
Graham Number56.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROCE | 18.66% | ||
| ROIC | 13.45% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 16.26% | ||
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% | ||
| FCFM | 6.21% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.34% | ||
| Profit Quality | 56.58% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 4.82 |
F-Score6
WACC7.09%
ROIC/WACC1.9
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.6%
Revenue Next 5Y6.02%
EBIT growth 1Y16.7%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year50.23%
EBIT Next 3Y28.55%
EBIT Next 5Y19.11%
FCF growth 1Y37.23%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y166.77%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 23.31 and the Price/Book (PB) ratio is 6.2.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.